Assistant Professor of Speech-Language Pathology at the University of Montana.
Serial entrepreneur investing in tech-med and tech-bio companies
Ex-CEO of Wadhwani Institute for Artificial Intelligence.
Senior Commercial Executive across PE, founder-led & blue-chip businesses, currently Managing Director at Careline365
MD, MPH, MBA - MD from Makerere, MPH from Harvard and MBA from Isenberg School
Associate Professor of Speech and Language Pathology at the University of Montana.
Dr. Daley is an International Expert in Mycobacterial and Respiratory Infections
Professor of Respiratory Medicine, Faculty of Medicine, National Heart & Lung Institute Imperial College London
Dr. Daley is an International Expert in Mycobacterial and Respiratory Infections
Dr. Daley is an international authority on respiratory infections and has served on expert panels for the WHO, CDC, IDSA, and ATS including as chair of the recently published Guidelines for the Management of NTM Pulmonary Disease. Dr. Daley received the ATS Global Lung Health Award in 2016 for his work with MDR-TB. Dr. Daley was an Associate Editor for the American Journal of Respiratory and Critical Care Medicine and now serves an Associate Editor for the European Respiratory Journal. As a scientist, Dr. Daley is actively involved in clinical, epidemiologic, and translational investigations of mycobacterial infections and bronchiectasis that has resulted in over 200 research publications, chapters and reviews. As a clinician, he focuses on the care of patients with bronchiectasis, NTM infections and drug resistant tuberculosis
